Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Inex and Bayer end antibiotic research collaboration

Dec. 20, 1996

Tetracycline antibacterial agents under study at Pfizer

Dec. 20, 1996

MedImmune receives patent coverage for RespiGam

Dec. 19, 1996

Carbapenem esters revealed by SKB

Dec. 18, 1996

BMS in-licenses antifungal triazole from Eisai

Dec. 13, 1996

RSV MAb from MedImmune enters pivotal trials

Dec. 13, 1996

Favorable phase I/II data presented for Xoma's Neuprex as pediatric meningococcemia treatment

Dec. 12, 1996

New antiviral agents from CNRS

Dec. 12, 1996

Milestone reached in Cubist/BMS antiinfective drug collaboration

Dec. 11, 1996

Positive results of fomivirsen in the treatment of CMV retinitis

Dec. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...